BDBM303131 US10137202, Compound TAM471

SMILES CCCO[C@H](C[C@H](C(C)C)N(CCC)C(=O)[C@@H](NC(=O)[C@H]1CCCCN1C)[C@@H](C)CC)c1nc(C(=O)N[C@@H](Cc2ccc(O)cc2)C[C@H](C)C(=O)NNC(=O)OCc2ccc(NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](NC(=O)CCCCCN3C(=O)C=CC3=O)C(C)C)cc2)cs1

InChI Key InChIKey=ABPJRWXABDCVSL-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 303131   

TargetProlyl endopeptidase FAP(Human)
Oncomatryx Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 303131BDBM303131(US10137202, Compound TAM471)
Affinity DataIC50: 29.5nMAssay Description:cell proliferation arrest on HT1080 cells (CPA; crystal violet).More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetProlyl endopeptidase FAP(Human)
Oncomatryx Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 303131BDBM303131(US10137202, Compound TAM471)
Affinity DataIC50: 1.40E+4nMAssay Description:TPI; Tubulin Polymerization assay kit; Cytoskeleton, Cat. #BK011P.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent